Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Trulieve Cannabis (TCNNF) Payables (2020 - 2025)

Trulieve Cannabis has reported Payables over the past 6 years, most recently at $86.7 million for Q4 2025.

  • Quarterly results put Payables at $86.7 million for Q4 2025, down 58.92% from a year ago — trailing twelve months through Dec 2025 was $86.7 million (down 58.92% YoY), and the annual figure for FY2025 was $86.7 million, down 58.92%.
  • Payables for Q4 2025 was $86.7 million at Trulieve Cannabis, up from $85.0 million in the prior quarter.
  • Over the last five years, Payables for TCNNF hit a ceiling of $211.1 million in Q4 2024 and a floor of $24.1 million in Q1 2022.
  • Median Payables over the past 5 years was $96.4 million (2022), compared with a mean of $121.6 million.
  • Biggest five-year swings in Payables: soared 324.25% in 2023 and later tumbled 59.95% in 2025.
  • Trulieve Cannabis' Payables stood at $104.1 million in 2021, then surged by 83.01% to $190.6 million in 2022, then increased by 7.54% to $204.9 million in 2023, then increased by 3.02% to $211.1 million in 2024, then tumbled by 58.92% to $86.7 million in 2025.
  • The last three reported values for Payables were $86.7 million (Q4 2025), $85.0 million (Q3 2025), and $82.7 million (Q2 2025) per Business Quant data.